Renal Cancer - Results from #80

Double Hit in Clear-Cell Renal Cell Carcinoma With Germline Pathogenic ATM Mutation and Somatic VHL Mutation. October 8, 2024

Quantifying preserved renal volume and function in patients undergoing standard partial nephrectomy vs. tumor enucleation for localized renal tumors. October 8, 2024

Toward a CRISPR-based mouse model of Vhl-deficient clear cell kidney cancer: Initial experience and lessons learned. October 7, 2024

Differences in the treatment patterns of small renal masses: A disaggregated analyses by race/ethnicity. October 7, 2024

Multivariate analysis of the parameters affecting the choice of surgical treatment for patients with localized renal cell carcinoma (RCC). October 4, 2024

Aristolochic acid-related renal cell carcinoma exhibits a distinct tumor-immune microenvironment favoring response to immune checkpoint blockade. October 4, 2024

Clear cell renal cell carcinoma micrometastasis: Insights from an unconventional cutaneous presentation. October 3, 2024

Understanding Treatment Decisions and Management for Patients with Advanced Renal Cell Carcinoma Using Hypothetical Case Studies: A Vodcast. October 3, 2024

Tumor Characteristics Associated With Preoperatively Detectable Tumor-Informed Circulating Tumor DNA in Patients With Renal Masses Suspicious for Renal Cell Carcinoma. October 2, 2024

Pembrolizumab-Induced Myasthenia Gravis With Myocarditis in the Setting of Metastatic Renal Cell Carcinoma. October 2, 2024

Factors that Affect Outcome of Ultrasound-Guided Radiofrequency Ablation of Renal Masses. October 1, 2024

Multi-sequence MRI-based radiomics model to preoperatively predict the WHO/ISUP grade of clear Cell Renal Cell Carcinoma: a two-center study. October 1, 2024

Imaging in Renal Cell Carcinoma Detection. September 30, 2024

The immunotherapy-based combination associated score as a robust predictor for outcome and response to combination of immunotherapy and VEGF inhibitors in renal cell carcinoma. September 30, 2024

EVEREST: Attempting the Summit with Adjuvant Everolimus To Treat High-risk Renal Cell Carcinoma After Surgery. September 29, 2024

Radiation Therapy for the Management of Renal Medullary Carcinoma: A Multi-Case Study. September 29, 2024

Performance of PSMA-targeted radiotheranostics in an experimental model of renal cell carcinoma. September 27, 2024

Oncologic surveillance after surgical treatment for clinically localized kidney cancer: UroCCR study n. 129. September 27, 2024

Clinical application of radiomics for the prediction of treatment outcome and survival in patients with renal cell carcinoma: a systematic review. September 27, 2024

Renal Cell Carcinoma with a Catastrophic Thrombus: A Case Report. September 27, 2024

Page 5 of 455